The Beaumont Enterprise on MSN
Lifelong patient reflects on 74 years of progress in diabetes care
Orange native Frank McCoy reflects on the evolution of diabetes care and how it has allowed him to live 74 years with Type 1 ...
The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, ...
According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...
According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 billion by 2033, growing at a strong CAGR of 8.8% from ...
Interesting Engineering on MSN
Students develop closed-loop insulin pump software that could ease diabetes burden
While insulin pumps and continuous glucose monitors have improved the lives of many Type 1 diabetes patients, some still ...
Everyday Health on MSN
Should You Be Using Automated Insulin Delivery (AID) for Type 1 Diabetes?
AID systems combine an insulin pump with a continuous glucose monitor to automatically adjust insulin levels throughout the ...
Despite rapid advancements in diabetes care, a dog’s nose is just as powerful in detecting blood sugar changes.
NASHVILLE, Tenn. (Ivanhoe Newswire) — The number of adults living with diabetes worldwide has surpassed 800 million, and the World Health Organization calls Type 2 diabetes an epidemic. But new ...
PORT ORANGE, Fla. — In November 2022, Hurricane Nicole came through Central Florida, resulting in the destruction of homes along Florida’s east coast. A collapsed retaining wall meant to protect the ...
PORTLAND, Ore., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Northwest Pump & Equipment Co. (“Northwest Pump”) is pleased to announce the acquisition of Orange Coast Petroleum Equipment (“OCPE”), a full-service ...
With Fortune Korea Top 40 recognition and the ‘M.A.P. Your Health’ campaign, Orange Biomed’s novel microfluidic A1C test is transforming diabetes care. A unique opportunity to demonstrate how our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results